MedTrace Logo

Diagnostic Tools for Parkinson's Disease

NCT02403765 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-11-04

No results posted yet for this study

Summary

The study aims to identify genetic variants associated to Parkinson's disease through the analysis of exome-sequencing data of familial cases and controls. The identified variants will be used to generate a diagnostic tool for the identification of genetic risk profiles.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • Neuromed IRCCS

    lead OTHER

Principal Investigators

  • Antonio Simeone · IRCCS Neuromed

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-10-31
Completion
2019-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02403765 on ClinicalTrials.gov